Inhibitory mechanisms of YC-1 and PMC in the induction of iNOS expression by lipoteichoic acid in RAW 264.7 macrophages

Biochemical Pharmacology

Volumn 67, Issue 7, 2004, Pages 1411-1419

  Hsiao, George ^a   Huang, Hsin Yi ^a   Fong, Tsorng Harn ^a   Shen, Ming Yi ^a   Lin, Chien Huang ^a   Teng, Chen Ming ^b   Sheu, Joen Rong ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

BHA; Butylated hydroxyanisole; ERK; Extracellular signal regulated kinase; I B ; IFN ; Inducible nitric oxide synthase; INOS; Interferon ; JAK STAT; Lipopolysaccharide; Lipoteichoic acid; LPS; LTA; NF B inhibitory protein

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; 6 HYDROXY 2,2,5,7,8 PENTAMETHYLCHROMAN; ALPHA TOCOPHEROL DERIVATIVE; ANTIOXIDANT; GUANYLATE CYCLASE ACTIVATOR; I KAPPA B ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOTEICHOIC ACID; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN; NITRIC OXIDE; NITRITE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REPRESSION; GENE EXPRESSION; HYPOTENSION; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CHROMANS; DRUG INTERACTIONS; ENZYME ACTIVATION; GENE EXPRESSION; INDAZOLES; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; RATS; RATS, WISTAR; RNA, MESSENGER; SHOCK, SEPTIC; TEICHOIC ACIDS;

EID: 1542375423     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2003.12.010     Document Type: Article

References (32)

1. Bone R.C. The pathogenesis of sepsis. Ann. Intern. Med. 115:1991;457-469.
2. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-143.
3. Taylor B.S., Geller D.A. Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene. Shock. 13:2000;413-424.
4. Nathan C., Xie Q.W. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269:1994;13725-13728.
5. Chartrain N.A., Geller D.A., Koty P.P., Sitrin N.F., Nussler A.K., Hoffman E.P., Billiar T.R., Hutchinson N.I., Mudgett J.S. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J. Biol. Chem. 296:1994;6765-6772.
6. Chen C.C., Wang J.K. p38 but not p44/42 mitogen activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages. Mol. Pharmacol. 55:1999;481-488.
7. Wicken A.J., Knox K.W. Lipoteichoic acid: new class of bacterial antigen. Science. 187:1975;1161-1167.
8. Lonchampt M.O., Auguet M., Delaflotte S., Goulin-Schulz J., Chabrier P.E., Braquet P. Lipoteichoic acid: a new inducer of nitric oxide synthase. J. Cardiovasc. Pharmacol. 20:1992;s145-s147.
9. Kengatharan M., De Kimpe S.J., Thiemermann C., Vane J.R. Characterization of the mechanism of enhanced nitrite formation by lipoteichoic acid (from S. aureus) in cultured J 774.2 macrophage cells. Br. J. Pharmacol. 115:1995;9P.
10. Sheu J.R., Lee C.R., Hsiao G., Hung W.C., Lee Y.M., Chen Y.C., Yen M.H. Comparison of the relative activities of α-tocopherol and PMC on platelet aggregation and antioxidative activity. Life Sci. 65:1999;197-206.
11. Sheu J.R., Lee C.R., Lin C.C., Kan Y.C., Lin C.H., Hung W.C., Lee Y.M., Yen M.H. The antiplatelet activity of PMC, a potent α-tocopherol analogue is mediated through inhibition of cyclooxygenase. Br. J. Pharmacol. 127:1999;1206-1212.
12. Suzuki Y.J., Packer L. Inhibition of NF-kappa B activation by Vitamin E derivatives. Biochem. Biophys. Res. Commun. 193:1993;277-283.
13. Wu C.C., Ko F.N., Kuo S.C., Lee F.Y., Teng C.M. YC-1 inhibits human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Br. J. Pharmacol. 116:1995;1973-1978.
14. Rothermund L., Friebe A., Paul M., Koesling D., Kreutz R. Acute blood pressure effects of YC-1-induced activation of soluble guanylyl cyclase in normotensive and hypertensive rats. Br. J. Pharmacol. 130:2000;205-208.
15. G-methyl-arginine. Biochem. Biophys. Res. Commun. 170:1990;96-103.
16. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Meth. 65:1983;55-63.
17. Hsiao G., Shen M.Y., Chang W.C., Cheng Y.W., Pan S.L., Kuo Y.H., Chen T.F., Sheu J.R. A novel antioxidant, octyl caffeate, suppression of LPS/IFN-γ-induced inducible nitric oxide synthase gene expression in rat aortic smooth muscle cells. Biochem. Pharmacol. 65:2003;1383-1392.
18. Marczin N., Carolyn Y.G., Catravas J.D. Induction of nitric oxide synthase by protein synthesis inhibition in aortic smooth muscle cells. Br. J. Pharmacol. 123:1998;1000-1008.
19. Zhao Y., Brandish P.E., DiValentin M., Schelvis J.P., Babcock G.T., Marletta M.A. Inhibition of soluble guanylate cyclase by ODQ. Biochemistry. 39:2000;10848-10854.
20. Porsti I., Paakkari I. Nitric oxide-based possibilities for pharmacotherapy. Ann. Med. 27:1995;407-420.
21. Kuo C.T., Chiang L.L., Lee C.N., Yu M.C., Bai K.J., Lee H.M., Lee W.S., Sheu J.R., Lin C.H. Induction of nitric oxide synthase in RAW 264.7 macrophages by lipoteichoic acid from Staphylococcus aureus: involvement of protein kinase C- and nuclear factor-κB-dependent mechanisms. J. Biomed. Sci. 10:2003;136-145.
22. Hattor Y., Kasai K., Akimoto K., Thiemermann C. Induction of NO synthesis by lipoteichoic acid from Staphylococcus aureus in J774 macrophages: involvement of a CD 14-dependent pathway. Biochem. Biophys. Res. Commun. 233:1997;375-379.
23. Grimm S., Baeuerle P.A. Review article: the inducible transcription factor NF-κB structure-function relationship of its protein subunits. Biochem. J. 290:1993;297-308.
24. Chan E.D., Riches D.W.H. Potential role of the JNK/SAPK signal transduction pathway in the induction of iNOS by TNF-α Biochem. Biophys. Res. Commun. 253:1998;790-796.
25. Meyer C.F., Wang X., Chang C., Templeton D., Tan T.H. Interaction between c-Rel and the mitogen-activated protein kinase kinase 1 signaling cascade in mediating kappa B enhancer activation. J. Biol. Chem. 271:1996;8971-8976.
26. Baeuerle P.A., Henkel T. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
27. Kengatharan M., De Kimpe S.J., Thiemermann C. Analysis of the signal transduction in the induction of nitric oxide synthase by lipoteichoic acid in macrophages. Br. J. Pharmacol. 117:1996;1163-1170.
28. Murohara T., Parkinson S.J., Waldman S.A., Lefer A.M. Inhibition of nitric oxide biosynthesis promotes P-selectin expression in platelets. Role of protein kinase C. Arterioscler. Thromb. Vasc. Biol. 15:1995;2068-2075.
29. Pérez-Sala D., Cernuda-Morollón E., Díaz-Cazorla M., Rodríguez-Pascual F., Lamas S. Posttranscriptional regulation of human iNOS by the NO/cGMP pathway. Am. J. Physiol. Renal Physiol. 280:2001;466-473.
30. Kiemer A.K., Vollmar A.M. Autocrine regulation of inducible nitric-oxide synthase in macrophages by atrial natriuretic peptide. J. Biol. Chem. 273:1998;13444-13451.
31. De Kimpe S.J., Hunter M.L., Bryant C.E., Thiemermann C., Vane J.R. Delayed circulatory failure due to the induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in anaesthetized rats. Br. J. Pharmacol. 114:1995;1317-1323.
32. Glauser M.P., Zanetti G., Baumgartner J.D., Cohen J. Septic shock: pathogenesis. Lancet. 338:1991;732-738.